Related Experiment Videos
Radiocontrast-induced nephropathy: current status and future prospects
K Margulies1, J Schirger, J Burnett
1Mayo Clinic, Rochester, MN.
Summary
Radiocontrast-induced nephropathy (RCIN) is a significant cause of acute kidney injury. Animal models suggest renal ischemia, tubular toxicity, and capillary permeability changes mediate RCIN, with hydration as a potential preventive measure.
Area of Science:
- Nephrology
- Radiology
- Cardiovascular Medicine
Background:
- Radiocontrast-induced nephropathy (RCIN) is a primary cause of hospital-acquired acute renal failure.
- Patients with pre-existing renal dysfunction, diabetes mellitus, or severe congestive heart failure face elevated risks.
- RCIN results from the intravascular administration of iodinated radiocontrast agents.
Purpose of the Study:
- To elucidate the pathophysiologic mechanisms underlying radiocontrast-induced nephropathy.
- To identify potential therapeutic and prophylactic strategies for RCIN.
Main Methods:
- Utilized three recently developed animal models to investigate RCIN.
- Examined the roles of transient renal ischemia, direct renal tubular toxicity, and altered glomerular capillary permeability.
Main Results:
- Animal models provided critical insights into RCIN pathophysiology.
- Identified potential mediators including renal ischemia, tubular toxicity, and glomerular capillary permeability changes.
- These mechanisms are not mutually exclusive in causing RCIN.
Conclusions:
- No definitive treatment currently exists for radiocontrast-induced nephropathy.
- Adequate hydration may mitigate the risk of developing RCIN.
- Synthetic atrial natriuretic factor and mannitol show promise as prophylactic agents but require further validation.